iRhythm Holdings, Inc. (IRTC) FY2026 Q2 P&L / Income Statement

iRhythm Holdings, Inc. (IRTC) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue, net

224,172,000 US dollars

Cost of revenue

60,967,000 US dollars

Gross profit

163,205,000 US dollars

Total operating expenses

165,747,000 US dollars

Loss from operations

negative 2,542,000 US dollars

Total interest and other income, net

2,161,000 US dollars

Loss before income taxes

negative 381,000 US dollars

Income tax provision (benefit)

0 US dollars

Net loss

negative 381,000 US dollars

Contracted third-party payors

113,783,000 US dollars

Centers for Medicare & Medicaid Services

58,550,000 US dollars

Healthcare institutions

37,782,000 US dollars

Non-contracted third-party payors

14,057,000 US dollars

Research and development

19,843,000 US dollars

Acquired in-process research and development

299,000 US dollars

Selling, general and administrative

131,655,000 US dollars

Litigation settlements

13,950,000 US dollars

Impairment charges

0 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.